Amneal Pharmaceuticals Inc (AMRX)
6.65
-0.11
(-1.63%)
USD |
NASDAQ |
May 06, 16:00
6.65
0.00 (0.00%)
After-Hours: 17:34
Amneal Pharmaceuticals Profit Margin (Quarterly): -15.99% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -15.99% |
| September 30, 2023 | 1.56% |
| June 30, 2023 | 1.99% |
| March 31, 2023 | -1.25% |
| December 31, 2022 | -0.71% |
| September 30, 2022 | -0.49% |
| June 30, 2022 | -21.60% |
| March 31, 2022 | -0.43% |
| December 31, 2021 | -1.19% |
| September 30, 2021 | -0.80% |
| June 30, 2021 | 2.72% |
| March 31, 2021 | 1.36% |
| December 31, 2020 | -0.60% |
| September 30, 2020 | -1.73% |
| Date | Value |
|---|---|
| June 30, 2020 | -2.58% |
| March 31, 2020 | 23.08% |
| December 31, 2019 | -8.09% |
| September 30, 2019 | -70.06% |
| June 30, 2019 | -4.18% |
| March 31, 2019 | -10.73% |
| December 31, 2018 | -1.76% |
| September 30, 2018 | 1.46% |
| June 30, 2018 | -53.03% |
| March 31, 2018 | 18.73% |
| December 31, 2017 | 20.99% |
| September 30, 2017 | 10.51% |
| June 30, 2017 | 14.41% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-70.06%
Minimum
Sep 2019
23.08%
Maximum
Mar 2020
-5.21%
Average
-0.80%
Median
Sep 2021
Profit Margin (Quarterly) Benchmarks
| Fate Therapeutics Inc | -2.63K% |
| Ocular Therapeutix Inc | -197.4% |
| Editas Medicine Inc | -31.43% |
| AnaptysBio Inc | -468.8% |
| AEON Biopharma Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -56.72% |
| Return on Assets | -2.30% |
| Return on Invested Capital | -2.94% |
| Gross Profit Margin (Quarterly) | 30.77% |
| Operating Margin (Quarterly) | 5.55% |
| Return on Net Operating Assets | -2.42% |